Clinical Trials
Recent cancer clinical trials sourced from ClinicalTrials.gov. Trials are listed for informational purposes only. Always consult your healthcare provider before making decisions about clinical trial participation.
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Pediatric, Acute Myeloid Leukemia in Children, Myeloproliferative Neoplasm
Interventions: MRF with neurocognative studies
NCT06421155 - View on ClinicalTrials.gov →A Study of Revumenib and Mezigdomide in People With Leukemia
Conditions: Leukemia, Acute Leukemia, Relapse Leukemia, Refractory Leukemia, Refractory Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
Interventions: Revumenib, Mezigdomide
NCT07356154 - View on ClinicalTrials.gov →EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Conditions: Pancreatic Disease, Pancreatic Cancer, Pancreatic Cyst, Gastrointestinal Tumor, Bile Duct Diseases, Bile Duct Cancer, Lymph Node Disease, Submucosal Tumor of Gastrointestinal Tract, Gastrointestinal Cancer
Interventions: Endoscopic ultrasound examination
NCT06340620 - View on ClinicalTrials.gov →Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Conditions: Large Cell Neuroendocrine Carcinoma, Large Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC), Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Small Cell Lung Cancer (SCLC), Gastroenteropancreatic NEC (GEP NEC), NEC of the Bladder, Other DLL3 Expressing epNEC
Interventions: [212Pb]Pb-MP0712, [203Pb]Pb-MP0712
NCT07278479 - View on ClinicalTrials.gov →Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
Conditions: Breast Cancer, Medico-economic Impact, Breast Cancer Surgery
Interventions: magnetic clip localization, metallic wire localization., Breast cancer surgery
NCT06906601 - View on ClinicalTrials.gov →Breast Cancer Risk Assessment in Night Shift Workers - Implementation of a Personalized Consultation
Conditions: Breast Neoplasms Diagnosis
Interventions: Personalized Prevention Plan
NCT07630935 - View on ClinicalTrials.gov →Quality of Life After Breast Cancer Surgery
Conditions: Breast Cancer Surgery, Quality of Life
Interventions: Questionnaire
NCT06761196 - View on ClinicalTrials.gov →A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Conditions: Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Carcinoma, Thymic, Anal Cancer, Mesothelioma, Esophagogastric Cancer, High Microsatellite Instability Colorectal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms
Interventions: KFA115, pembrolizumab
NCT05544929 - View on ClinicalTrials.gov →Clinical TrialA research study that tests a medical intervention in human volunteers.Click for full explanation → of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
Conditions: Breast Cancer
Interventions: TQB3126
NCT07697443 - View on ClinicalTrials.gov →First-in-human Trial of STC-1010, an ImmunotherapyTreatments that use the body's immune system to fight cancer.Click for full explanation →, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Conditions: Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Interventions: STC-1010 + IS regimen + SOC therapy
NCT06934538 - View on ClinicalTrials.gov →Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Paranasal Sinus Neoplasms, Nasopharyngeal Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer, Carcinoma of Larynx, Oral Squamous Cell Carcinoma, Salivary Gland Cancer, Adenoid Cystic Carcinoma, Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
Interventions: SX-682, DTX
NCT07667400 - View on ClinicalTrials.gov →Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Conditions: Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer, Gastroesophageal Adenocarcinoma, Gastroesophageal Cancer (GC), Gastroesophageal Junction (GEJ) Adenocarcinoma, Gastroesophageal Junction (GEJ) Cancer, Gastrointestinal Cancer Metastatic, Gastrointestinal Adenocarcinoma, Gastrointestinal Cancers, Colorectal (Colon or Rectal) Cancer, Pancreatic Cancer, CDH17-positive Advanced Solid Tumors, Advanced Gastric Cancer
Interventions: BHB810
NCT07529808 - View on ClinicalTrials.gov →Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Conditions: Malnutrition (Calorie), Colorectal Cancer, Lung Cancer
Interventions: Fortimel Forticare Sensations
NCT07255066 - View on ClinicalTrials.gov →Anti-CRLF2-R/TSLPR Chimeric Antigen ReceptorA type of immunotherapy that genetically engineers a patient's own T cells to recognise and destroy cancer cells.Click for full explanation → T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Conditions: B-All, Acute Lymphoblastic Leukemia
Interventions: TSLPR-CART, Cyclophosphamide, Fludarabine
NCT07572136 - View on ClinicalTrials.gov →A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
Interventions: INR731, Enzalutamide, Abiraterone, Androgen deprivation therapy (ADT)
NCT07570979 - View on ClinicalTrials.gov →A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Conditions: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
Interventions: Sacituzumab tirumotecan, Fluorouracil (5-FU), Leucovorin (LV) or levoleucovorin, Rescue medication, Supportive care measures, Cisplatin, Pembrolizumab
NCT06428409 - View on ClinicalTrials.gov →A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRASOne of the most common cancer-driving mutations, found in lung, colon, and pancreatic cancers.Click for full explanation → G12D MutationA change in DNA sequence that can drive cancer development.Click for full explanation →
Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: Setidegrasib, Docetaxel
NCT07566052 - View on ClinicalTrials.gov →A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Conditions: Head and Neck Cancer, Head and Neck Tumor, Thoracic Tumor, Thoracic Cancer, Gynecologic Cancer, Gynecologic Tumor, Melanoma, Ovarian Cancer
Interventions: IM@Home, Enhanced usual care
NCT05053230 - View on ClinicalTrials.gov →EUS Procedures Using RIVOS™ EUS Access Device
Conditions: Pancreatic Fluid Collections, Biliary Obstruction, Pancreatic Duct Obstruction, Chronic Pancreatitis, Pancreatic Cancer Non-resectable
Interventions: EUS-guided intervention using the RIVOS™ EUS access device
NCT07696572 - View on ClinicalTrials.gov →A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, mCRPC, mCRPC, mCRPC (Metastatic Castration-resistant Prostate Cancer)
Interventions: KTX-2001, KTX-2001 + Darolutamide (NUBEQA®)
NCT07103018 - View on ClinicalTrials.gov →Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With ChemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation → in Adults With Advanced Colorectal Cancer
Conditions: Advanced Microsatellite Stable Colorectal Cancer
Interventions: Denikitug, Nivolumab, Bevacizumab, Trifluridine-Tipiracil
NCT07527858 - View on ClinicalTrials.gov →Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
Conditions: Prostate Cancer Recurrent, Prostate Cancer
Interventions: High Dose Rate Brachytherapy
NCT06508567 - View on ClinicalTrials.gov →Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Conditions: Non Small Cell Lung Carcinoma, c-MET
Interventions: Telisotuzumab Adizutecan, Budigalimab, Pembrolizumab, Pembrolizumab, Carboplatin, Pemetrexed, Cisplatin
NCT06772623 - View on ClinicalTrials.gov →A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Conditions: Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, Prostate Cancer, TNBC - Triple-Negative Breast Cancer, GastroEsophageal Cancer, Bladder Cancer
Interventions: BG-68501, Fulvestrant, BGB-43395
NCT06257264 - View on ClinicalTrials.gov →Dabrafenib and/or Trametinib Rollover Study
Conditions: Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma
Interventions: dabrafenib, trametinib
NCT03340506 - View on ClinicalTrials.gov →A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
Conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Low-volume Metastasis
Interventions: Darolutamide (BAY1841788) + docetaxel + ADT
NCT06661122 - View on ClinicalTrials.gov →DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Conditions: Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Interventions: obrixtamig, atezolizumab, carboplatin, etoposide
NCT07472517 - View on ClinicalTrials.gov →MOONRAY-01, A Study of LY3962673 in Participants With KRASOne of the most common cancer-driving mutations, found in lung, colon, and pancreatic cancers.Click for full explanation → G12D-Mutant Solid Tumors
Conditions: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
Interventions: LY3962673, Cetuximab, Gemcitabine, nab-paclitaxel, Oxaliplatin, leucovorin, Irinotecan, 5-fluorouracil
NCT06586515 - View on ClinicalTrials.gov →An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Conditions: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Enzalutamide, Placebo, Androgen deprivation therapy (ADT)
NCT04076059 - View on ClinicalTrials.gov →A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Neoadjuvant
Interventions: Carboplatin, Mirvetuximab Soravtansine, Bevacizumab
NCT06890338 - View on ClinicalTrials.gov →Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Conditions: Advanced Solid Tumors
Interventions: M7437, M7437
NCT07360314 - View on ClinicalTrials.gov →Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Conditions: Malignancy, Hematologic, Neoplasms, Hematologic, Neoplasms, Hematopoietic, Blood Cancer, Hematological Neoplasms, Hematopoietic Malignancies, Dysmyelopoietic Syndromes, Hematopoetic Myelodysplasia, Myeloid Leukemia, Acute, Nonlymphoblastic Leukemia, Acute, Leukemia, Lymphocytic, Acute
Interventions: aldesleukin, cyclophosphamide, fludarabine phosphate, Individual Patient TCR-Transduced PBL, TruSight Oncology (TSO) 500
NCT06904066 - View on ClinicalTrials.gov →A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Interventions: Opevesostat, Dexamethasone, Fludrocortisone acetate, Hydrocortisone, Abiraterone acetate, Prednisone acetate, Enzalutamide
NCT06136650 - View on ClinicalTrials.gov →Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL
Conditions: Pediatric Acute Leukemia
Interventions: Health monitoring & reminders for a mobile-phone portal for scheduling a telemedicine clinic visit and receive periodic model-phone messages instructing follow-up blood testing and dose adjustment.
NCT07278882 - View on ClinicalTrials.gov →Anal Cancer Radiotherapy Study
Conditions: Anal Cancer
NCT01937780 - View on ClinicalTrials.gov →Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Conditions: Low-Risk, Early Stage Breast Cancer
Interventions: Cryoablation
NCT07629206 - View on ClinicalTrials.gov →Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
Conditions: CRC Screening, Microbiome
Interventions: Gixam System, FIT, Standard of care screening colonoscopy
NCT07623902 - View on ClinicalTrials.gov →A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Conditions: Non-small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma
Interventions: HLX17, US-sourced Keytruda®
NCT07160335 - View on ClinicalTrials.gov →Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy
Conditions: Prostate Cancer, Bladder Cancer, Surgery, Renal Impairment, Renal Injury, Acute
Interventions: Nitroglycerin Infusion, Mannitol Infusion, Fluid Regimen
NCT06408597 - View on ClinicalTrials.gov →An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Conditions: Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer
Interventions: Darolutamide (Nubeqa, BAY1841788)
NCT06334120 - View on ClinicalTrials.gov →